Brainstorm Cell Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BCLI and other ETFs, options, and stocks.

About BCLI

Brainstorm Cell Therapeutics, Inc. operates as a biotechnology company, which develops and commercializes adult stem cell therapeutic products. It focuses on utilizing the patients own bone marrow stem cells to generate neuron-like cells that may provide an effective treatment initially for amyotrophic lateral sclerosis, Parkinson's disease, multiple sclerosis and spinal cord injury. 

CEO
Chaim Lebovits
CEOChaim Lebovits
Employees
43
Employees43
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2000
Founded2000
Employees
43
Employees43

BCLI Key Statistics

Market cap
152.15M
Market cap152.15M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
263.05K
Average volume263.05K
High today
$4.24
High today$4.24
Low today
$4.11
Low today$4.11
Open price
$4.15
Open price$4.15
Volume
107.28K
Volume107.28K
52 Week high
$4.70
52 Week high$4.70
52 Week low
$2.52
52 Week low$2.52

BCLI Earnings

-$0.43
-$0.29
-$0.14
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 14, Pre-Market
ActualExpected Nov 14, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.